To investigate the potential roles of KCNMA1 in the glioma cell line with BRAFV600E mutation, two shRNA targeting non-overlapping regions of KCNMA1 transcript were individually cloned into lentivirus derived vectors and introduced into the DBTRG-05MG cell line. This evidence concerns the gene KCNMA1 and central nervous system cancer.